What is the recommended intrapartum fetal surveillance for a multi-gravida (multiple pregnancy) woman at 38 weeks of gestation with intrauterine growth restriction (IUGR) undergoing induction of labor, who is otherwise medically free?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Intrapartum Fetal Surveillance

Continuous electronic fetal monitoring (continuous CTG) is the recommended intrapartum surveillance method for this multigravida at 38 weeks undergoing induction of labor for IUGR. 1

Rationale for Continuous Monitoring

The evidence strongly supports continuous electronic fetal monitoring during labor for IUGR cases:

  • UK, New Zealand, and French guidelines explicitly recommend induction of labor with continuous CTG when umbilical artery end-diastolic flow is present in IUGR cases. 1

  • The Society for Maternal-Fetal Medicine emphasizes that continuous fetal monitoring in labor is essential for fetal growth restriction, even though routine cesarean delivery is not recommended. 1

  • IUGR fetuses can quickly decompensate once uterine contractions have started, making careful continuous monitoring crucial during labor. 2

Why Not Intermittent Auscultation?

Intermittent fetal auscultation is inappropriate in this clinical scenario because:

  • IUGR fetuses with abnormal placental function are at significantly increased risk for intrapartum fetal heart rate decelerations, emergency cesarean delivery, and metabolic acidemia. 3

  • The fetus should be monitored continuously during labor to minimize fetal hypoxia in growth-restricted pregnancies. 4

  • Vaginal delivery with continuous electronic fetal monitoring is the appropriate approach when umbilical artery end-diastolic flow remains present, according to ACOG. 5

Additional Surveillance Components

While continuous fetal monitoring is the primary surveillance method, comprehensive intrapartum care includes:

  • Maternal vital signs monitoring should be performed regularly to detect any maternal complications, particularly if preeclampsia develops or was present. 6

  • Uterine activity monitoring is inherently part of continuous CTG, which tracks both fetal heart rate and uterine contractions simultaneously. 1

Critical Clinical Pitfall

Do not attempt to use intermittent auscultation or reduce monitoring intensity based on reassuring prenatal testing. The intrapartum period represents a critical stress test for the IUGR fetus with compromised placental reserve, and continuous monitoring is essential to detect early signs of fetal decompensation that may require urgent cesarean delivery. 3, 2

References

Guideline

Intrapartum Fetal Surveillance for IUGR at 38 Weeks

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Intrauterine restriction (IUGR).

Journal of perinatal medicine, 2008

Guideline

Timing of Delivery for Fetal Growth Restriction (FGR) with Abnormal Dopplers

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Fetal Growth Restriction at 36 Weeks Gestation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Prognostic factors for successful induction of labor in intrauterine growth restriction after 36 weeks of gestation.

European journal of obstetrics, gynecology, and reproductive biology, 2022

Related Questions

What is the most appropriate next step in management for a pregnant woman at 20 weeks gestation with a history of intrauterine growth restriction (IUGR) in a previous pregnancy?
What are the parameters for managing a fetus with Intrauterine Growth Restriction (IUGR)?
What is the most appropriate next step in management for a pregnant woman at 38 weeks of gestation diagnosed with intrauterine growth restriction (IUGR) and an amniotic fluid index (AFI) of 3 cm?
What is the most appropriate next step in management for a pregnant woman at 38 weeks of gestation diagnosed with intrauterine growth restriction (IUGR) and an amniotic fluid index (AFI) of 3 cm?
What is the management for a fetus with intrauterine growth restriction (IUGR)?
What is the best initial management for an elderly patient with urinary retention and bleeding after a Transurethral Resection of the Prostate (TURP), should I place a new catheter in the Emergency Department (ED) or consult urology?
What is on-demand therapy with omeprazole (Proton Pump Inhibitor (PPI)) for a typical adult patient with no significant medical history experiencing intermittent acid reflux or heartburn symptoms?
Do adult males with erectile dysfunction develop tolerance to phosphodiesterase-5 (PDE5) inhibitors like sildenafil (sildenafil) or tadalafil (tadalafil)?
What health recommendations and screenings are advised for a 36-year-old male with no specified symptoms or medical history?
What are the recommendations for using AOD 9604 (Anti-Obesity Drug 9604) for weight loss in an adult patient with potential metabolic disorders?
What is the diagnosis and management for a 36-year-old with abdominal pain, significant weight loss, night sweats, and epigastric tenderness, prescribed pantoprazole (proton pump inhibitor) and Buscopan (antispasmodic)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.